Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CBLI

Cleveland BioLabs (CBLI) Stock Price, News & Analysis

Cleveland BioLabs logo

About Cleveland BioLabs Stock (NASDAQ:CBLI)

Advanced Chart

Key Stats

Today's Range
$0.0002
$0.0002
50-Day Range
$2.20
$4.34
52-Week Range
$1.62
$10.97
Volume
206 shs
Average Volume
271,922 shs
Market Capitalization
$3.10 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CBLI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cleveland BioLabs and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CBLI Stock News Headlines

Cleveland Construction News
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis.tc pixel
Best Hospitals in Cleveland, OH
Cleveland Clinic Rehabilitation Hospital
Getting Around Cleveland
See More Headlines

CBLI Stock Analysis - Frequently Asked Questions

Cleveland BioLabs, Inc. (NASDAQ:CBLI) issued its quarterly earnings results on Friday, May, 15th. The biotechnology company reported ($0.05) earnings per share (EPS) for the quarter. The biotechnology company earned $0.16 million during the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cleveland BioLabs investors own include iBio (IBIO), Inovio Pharmaceuticals (INO), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Dynavax Technologies (DVAX), Novavax (NVAX) and BioCryst Pharmaceuticals (BCRX).

Company Calendar

Last Earnings
5/15/2020
Today
8/29/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CBLI
CIK
1318641
Fax
N/A
Employees
4
Year Founded
2003

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.40 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-32.84%
Return on Assets
-31.29%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
45.93
Quick Ratio
45.93

Sales & Book Value

Annual Sales
$260 thousand
Price / Sales
0.01
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.87 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
15,479,000
Free Float
N/A
Market Cap
$3.10 thousand
Optionable
Not Optionable
Beta
0.70

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:CBLI) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners